Lutter, France

Theresa Maria Ballard

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Basel, CH (2005)
  • Lutter, FR (2007 - 2018)

Company Filing History:


Years Active: 2005-2018

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Theresa Maria Ballard

Introduction

Theresa Maria Ballard is a prominent inventor based in Lutter, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating various cognitive and psychological disorders. With a total of four patents to her name, Ballard's work has garnered attention for its potential impact on healthcare.

Latest Patents

Among her latest patents, Ballard has developed pyrrolopyridine and pyrazolopyridine derivatives. These compounds are designed to address various medical conditions, including Alzheimer's disease and cognitive impairment. Additionally, she has worked on indol and indazol derivatives, which may be used for the treatment or prophylaxis of schizophrenia, pain, and sleep disorders. The innovative nature of these compounds highlights her commitment to advancing medical science.

Career Highlights

Throughout her career, Ballard has been associated with notable companies such as Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. Her work in these organizations has allowed her to collaborate with leading experts in the field, further enhancing her contributions to pharmaceutical research and development.

Collaborations

Some of her notable coworkers include Emmanuel Pinard and Herve Schaffhauser. Their collaborative efforts have played a crucial role in the success of her projects and the advancement of their shared goals in the pharmaceutical industry.

Conclusion

Theresa Maria Ballard's innovative work and dedication to developing new pharmaceutical compounds have positioned her as a key figure in her field. Her contributions continue to pave the way for advancements in treatments for cognitive and psychological disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…